Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes

@inproceedings{Barnard2010ClinicalUO,
  title={Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes},
  author={Karen Barnard and Mary Elizabeth Cox and Jennifer B Green},
  booktitle={Diabetes, metabolic syndrome and obesity : targets and therapy},
  year={2010}
}
Adequate glycemic control in type 2 diabetes remains a difficult but achievable goal. The development of new classes of glucose-lowering medications, including in particular the incretin-based therapies, provides an opportunity to utilize combinations of medications which target multiple physiologic abnormalities in type 2 diabetes. Complementary… CONTINUE READING